US Stock MarketDetailed Quotes

ADCT ADC Therapeutics

Watchlist

2.700
-0.130-4.59%

Close Sep 6 16:00 ET

2.700
0.0000.00%

Post 19:24 ET

260.95MMarket Cap-1062P/E (TTM)

ADC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

6.12%-32.85M

-186.48%-44.1M

14.19%-118.69M

38.31%-33.07M

-1,705.15%-35.23M

34.00%-34.99M

54.57%-15.39M

40.74%-138.31M

13.01%-53.61M

103.75%2.2M

Net income from continuing operations

25.30%-36.54M

21.50%-46.61M

-52.78%-240.05M

-236.29%-85.7M

9.00%-46.05M

24.00%-48.92M

-256.37%-59.37M

31.69%-157.13M

25.87%-25.49M

29.27%-50.61M

Operating gains losses

-318.61%-1.63M

402.68%3.76M

-89.39%4.32M

-37.92%2.6M

-99.29%229K

-57.75%747K

-70.25%747K

564.72%40.69M

82.46%4.18M

1,351.94%32.23M

Depreciation and amortization

3.20%838K

16.60%843K

36.81%3.27M

58.96%1.01M

26.05%721K

38.57%812K

21.72%723K

-9.20%2.39M

-16.21%636K

-13.07%572K

Deferred tax

--0

2,388.96%37.1M

671.58%45.75M

-887.07%-3.47M

-23.41%-5.1M

98.21%-69K

93.78%-1.62M

122.76%5.93M

--441K

Other non cash items

-33.69%7.04M

349.13%6.93M

168.11%17.3M

-28.95%-6.1M

-22.35%11.25M

218.24%10.61M

105.89%1.54M

-48.97%-25.41M

49.54%-4.73M

30.12%14.49M

Change In working capital

-195.98%-4.82M

-130.15%-9.92M

190.86%44.27M

117.26%10.18M

17.39%-3.84M

-69.52%5.02M

2,221.92%32.91M

-210.15%-48.73M

-972.28%-59M

66.05%-4.65M

-Change in receivables

69.68%319K

-95.92%2M

211.78%47.79M

91.95%-4M

211.53%2.7M

-96.81%188K

1,310.88%48.9M

-41.48%-42.75M

-246.94%-49.69M

82.49%-2.42M

-Change in inventory

125.24%518K

-63.22%-568K

40.81%-5.71M

90.53%-332K

-59.96%-2.98M

47.75%-2.05M

1.97%-348K

-219.36%-9.65M

-69.95%-3.51M

-26,714.29%-1.86M

-Change in payables and accrued expense

-2,151.60%-7.03M

69.99%-4.79M

-166.26%-10.97M

-175.60%-9.26M

335.86%14.56M

90.86%-312K

-464.20%-15.96M

-14.29%16.56M

25.38%12.25M

93.79%3.34M

-Change in other current assets

-109.92%-445K

-209.02%-701K

164.15%7.49M

166.41%8.08M

-72.85%-5.72M

-7.71%4.49M

160.38%643K

-83.67%-11.67M

-310.77%-12.16M

-88.06%-3.31M

-Change in other current liabilities

-33.06%1.81M

-1,719.57%-5.86M

571.74%5.68M

366.67%15.69M

-326.68%-12.4M

-72.56%2.71M

96.98%-322K

---1.2M

---5.88M

--5.47M

Cash from discontinued investing activities

Operating cash flow

6.12%-32.85M

-186.48%-44.1M

14.19%-118.69M

38.31%-33.07M

-1,705.15%-35.23M

34.00%-34.99M

54.57%-15.39M

40.74%-138.31M

13.01%-53.61M

103.75%2.2M

Investing cash flow

Cash flow from continuing investing activities

97.52%-30K

47.74%-531K

-368.12%-3.22M

-130.93%-527K

-81.50%-461K

-75.91%-1.21M

29.83%-1.02M

89.70%-687K

305.30%1.7M

89.14%-254K

Net PPE purchase and sale

97.52%-30K

47.74%-531K

-368.12%-3.22M

-61.68%-346K

-230.93%-642K

-2,324.00%-1.21M

-343.67%-1.02M

79.97%-687K

49.05%-214K

86.19%-194K

Net intangibles purchase and sale

----

93.57%-60K

Net other investing changes

----

--0

Cash from discontinued investing activities

Investing cash flow

97.52%-30K

47.74%-531K

-368.12%-3.22M

-130.93%-527K

-81.50%-461K

-75.91%-1.21M

29.83%-1.02M

89.70%-687K

305.30%1.7M

89.14%-254K

Financing cash flow

Cash flow from continuing financing activities

35.01%98.7M

-16.24%356K

8,335.79%73.88M

159.56%1.64M

-154.59%-1.29M

29,108.73%73.1M

264.73%425K

-100.34%-897K

-125.94%-2.75M

-98.92%2.37M

Net issuance payments of debt

----

--0

-53.54%866K

----

137.79%115.6M

906.93%1.86M

49,987.77%114.24M

Net common stock issuance

----

--0

----

--6.13M

---62K

----

Proceeds from stock option exercised by employees

--41K

-16.24%356K

--773K

----

--0

--425K

--0

----

Net other financing activities

----

159.61%73.1M

--0

----

-156.25%-122.62M

-264.61%-4.55M

----

Cash from discontinued financing activities

Financing cash flow

35.01%98.7M

-16.24%356K

8,335.79%73.88M

159.56%1.64M

-154.59%-1.29M

29,108.73%73.1M

264.73%425K

-100.34%-897K

-125.94%-2.75M

-98.92%2.37M

Net cash flow

Beginning cash position

-24.56%234.29M

-14.66%278.6M

-30.03%326.44M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

6.23%466.54M

-28.17%380.86M

1.32%376.78M

Current changes in cash

78.37%65.82M

-176.98%-44.27M

65.67%-48.03M

41.53%-31.96M

-958.92%-36.99M

168.40%36.9M

55.09%-15.98M

-611.63%-139.9M

14.16%-54.66M

-97.28%4.31M

Effect of exchange rate changes

-80.33%12K

-148.31%-43K

188.46%184K

-37.45%152K

47.32%-118K

142.07%61K

208.54%89K

-3,566.67%-208K

737.93%243K

-229.41%-224K

End cash Position

-13.64%300.12M

-24.56%234.29M

-14.66%278.6M

-18.50%310.41M

-7.77%347.51M

-27.93%310.55M

-30.03%326.44M

-28.17%380.86M

Free cash flow

9.19%-32.88M

-171.98%-44.63M

12.30%-121.9M

35.92%-33.4M

-1,949.25%-35.89M

32.74%-36.2M

53.12%-16.41M

42.02%-139M

16.16%-52.12M

103.19%1.94M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	6.12%-32.85M	-186.48%-44.1M	14.19%-118.69M	38.31%-33.07M	-1,705.15%-35.23M	34.00%-34.99M	54.57%-15.39M	40.74%-138.31M	13.01%-53.61M	103.75%2.2M
Net income from continuing operations	25.30%-36.54M	21.50%-46.61M	-52.78%-240.05M	-236.29%-85.7M	9.00%-46.05M	24.00%-48.92M	-256.37%-59.37M	31.69%-157.13M	25.87%-25.49M	29.27%-50.61M
Operating gains losses	-318.61%-1.63M	402.68%3.76M	-89.39%4.32M	-37.92%2.6M	-99.29%229K	-57.75%747K	-70.25%747K	564.72%40.69M	82.46%4.18M	1,351.94%32.23M
Depreciation and amortization	3.20%838K	16.60%843K	36.81%3.27M	58.96%1.01M	26.05%721K	38.57%812K	21.72%723K	-9.20%2.39M	-16.21%636K	-13.07%572K
Deferred tax	--0	--0	2,388.96%37.1M	671.58%45.75M	-887.07%-3.47M	-23.41%-5.1M	98.21%-69K	93.78%-1.62M	122.76%5.93M	--441K
Other non cash items	-33.69%7.04M	349.13%6.93M	168.11%17.3M	-28.95%-6.1M	-22.35%11.25M	218.24%10.61M	105.89%1.54M	-48.97%-25.41M	49.54%-4.73M	30.12%14.49M
Change In working capital	-195.98%-4.82M	-130.15%-9.92M	190.86%44.27M	117.26%10.18M	17.39%-3.84M	-69.52%5.02M	2,221.92%32.91M	-210.15%-48.73M	-972.28%-59M	66.05%-4.65M
-Change in receivables	69.68%319K	-95.92%2M	211.78%47.79M	91.95%-4M	211.53%2.7M	-96.81%188K	1,310.88%48.9M	-41.48%-42.75M	-246.94%-49.69M	82.49%-2.42M
-Change in inventory	125.24%518K	-63.22%-568K	40.81%-5.71M	90.53%-332K	-59.96%-2.98M	47.75%-2.05M	1.97%-348K	-219.36%-9.65M	-69.95%-3.51M	-26,714.29%-1.86M
-Change in payables and accrued expense	-2,151.60%-7.03M	69.99%-4.79M	-166.26%-10.97M	-175.60%-9.26M	335.86%14.56M	90.86%-312K	-464.20%-15.96M	-14.29%16.56M	25.38%12.25M	93.79%3.34M
-Change in other current assets	-109.92%-445K	-209.02%-701K	164.15%7.49M	166.41%8.08M	-72.85%-5.72M	-7.71%4.49M	160.38%643K	-83.67%-11.67M	-310.77%-12.16M	-88.06%-3.31M
-Change in other current liabilities	-33.06%1.81M	-1,719.57%-5.86M	571.74%5.68M	366.67%15.69M	-326.68%-12.4M	-72.56%2.71M	96.98%-322K	---1.2M	---5.88M	--5.47M
Cash from discontinued investing activities
Operating cash flow	6.12%-32.85M	-186.48%-44.1M	14.19%-118.69M	38.31%-33.07M	-1,705.15%-35.23M	34.00%-34.99M	54.57%-15.39M	40.74%-138.31M	13.01%-53.61M	103.75%2.2M
Investing cash flow
Cash flow from continuing investing activities	97.52%-30K	47.74%-531K	-368.12%-3.22M	-130.93%-527K	-81.50%-461K	-75.91%-1.21M	29.83%-1.02M	89.70%-687K	305.30%1.7M	89.14%-254K
Net PPE purchase and sale	97.52%-30K	47.74%-531K	-368.12%-3.22M	-61.68%-346K	-230.93%-642K	-2,324.00%-1.21M	-343.67%-1.02M	79.97%-687K	49.05%-214K	86.19%-194K
Net intangibles purchase and sale	----	----	----	----	----	----	----	----	----	93.57%-60K
Net other investing changes	----	----	----	----	----	----	----	----	----	--0
Cash from discontinued investing activities
Investing cash flow	97.52%-30K	47.74%-531K	-368.12%-3.22M	-130.93%-527K	-81.50%-461K	-75.91%-1.21M	29.83%-1.02M	89.70%-687K	305.30%1.7M	89.14%-254K
Financing cash flow
Cash flow from continuing financing activities	35.01%98.7M	-16.24%356K	8,335.79%73.88M	159.56%1.64M	-154.59%-1.29M	29,108.73%73.1M	264.73%425K	-100.34%-897K	-125.94%-2.75M	-98.92%2.37M
Net issuance payments of debt	----	----	--0	-53.54%866K	----	----	----	137.79%115.6M	906.93%1.86M	49,987.77%114.24M
Net common stock issuance	----	----	--0	--0	--0	----	----	--6.13M	---62K	----
Proceeds from stock option exercised by employees	--41K	-16.24%356K	--773K	----	----	--0	--425K	--0	----	----
Net other financing activities	----	----	159.61%73.1M	--0	--0	----	----	-156.25%-122.62M	-264.61%-4.55M	----
Cash from discontinued financing activities
Financing cash flow	35.01%98.7M	-16.24%356K	8,335.79%73.88M	159.56%1.64M	-154.59%-1.29M	29,108.73%73.1M	264.73%425K	-100.34%-897K	-125.94%-2.75M	-98.92%2.37M
Net cash flow
Beginning cash position	-24.56%234.29M	-14.66%278.6M	-30.03%326.44M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	6.23%466.54M	-28.17%380.86M	1.32%376.78M
Current changes in cash	78.37%65.82M	-176.98%-44.27M	65.67%-48.03M	41.53%-31.96M	-958.92%-36.99M	168.40%36.9M	55.09%-15.98M	-611.63%-139.9M	14.16%-54.66M	-97.28%4.31M
Effect of exchange rate changes	-80.33%12K	-148.31%-43K	188.46%184K	-37.45%152K	47.32%-118K	142.07%61K	208.54%89K	-3,566.67%-208K	737.93%243K	-229.41%-224K
End cash Position	-13.64%300.12M	-24.56%234.29M	-14.66%278.6M	-14.66%278.6M	-18.50%310.41M	-7.77%347.51M	-27.93%310.55M	-30.03%326.44M	-30.03%326.44M	-28.17%380.86M
Free cash flow	9.19%-32.88M	-171.98%-44.63M	12.30%-121.9M	35.92%-33.4M	-1,949.25%-35.89M	32.74%-36.2M	53.12%-16.41M	42.02%-139M	16.16%-52.12M	103.19%1.94M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall